Clinical Trial Update: The Use of Anti-CD4 Monoclonal Antibody (mAb)-Fragment for the Imaging of Chronic Inflammation in Patients With Active Rheumatoid Arthritis [Phase 1, Phase 2]

View source ↗

Summary

The trial updates indicate completion of a Phase 1/2 study evaluating an anti-CD4 monoclonal antibody fragment for imaging chronic inflammation in active rheuma…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Polyarthritis
• Rheumatoid Arthritis

Drugs mentioned

• Anti-CD4 monoclonal antibody fragment (anti-CD4 monoclonal antibody fragment)

Snippet

Sponsor: Biotectid GmbH | Conditions: Rheumatoid Arthritis, Polyarthritis | Phase 1, Phase 2 | Status: COMPLETED